Tuesday, November 15, 2011

Lilly Drug Doubles Good Cholesterol in Ph2 Study - Nov. 15, 2011

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Tuesday, November 15, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Assay Depot has created the world's largest network of public and private cloud-based Research Exchanges

Life science researchers from 53 countries use our public Research Exchange to find, create and purchase research services and products and to communicate with 5000+ research vendors.

Pharmaceutical companies, universities and non-profit organizations use a private Research Exchange to manage and strengthen internal and external research partnerships.

Research vendors use public and private Research Exchanges to offer their services and products to the global research community.

Researchers - Use our free public marketplace at assaydepot.com.
Vendors - Get a free vendor account at http://backoffice.assaydepot.com/.
HeadHtml
•  Eli Lilly and Company (LLY) Drug Doubles Good Cholesterol in Phase II Study More...
•  Sanofi (France) (SASY.PA)'s Multaq Doubled Deaths from Heart Disease in Study More...
•  Theravance, Inc. (THRX) Announces Positive Results From a Phase 2a Study of Its LAMA Candidate, TD-4208, for the Treatment of COPD More...
•  Positive Results from Phase 2 Trial of Mesoblast Limited's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting More...
•  ProFibrix Phase II with FibrocapsTM Meets Primary Endpoint - On Track for Phase III in 2012 More...
More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
HeadHtml
•  Amgen (AMGN)'s Vectibix® (Panitumumab) Granted Approval for Expanded Indications in the European Union More...
More Drug Approval News
HeadHtml
•  NeurogesX, Inc. (NGSX) Receives FDA Acceptance for Review of sNDA for Qutenza(R) (capsaicin) 8% Patch for HIV-Associated Peripheral Neuropathy (HIV-PN) More...
•  Apricus Biosciences (APRI) Announces That Its NexACT(R) Partner Exodos Life Sciences Has Completed Its pre-IND Meeting With the FDA More...
More BLA/NDA/ANDA News
More IND News
More MAA News
Featured Free Resource

Quantifying the Value of Pipeline Pilot, the Accelrys Scientific Enterprise Platform

This white paper outlines the methodology, sources of value, and quantifiable results from bringing products to market faster, avoiding unproductive experiments, saving developer time, and more.

Request Now!
HeadHtml
•  Drinking Risky for Women With Family History of Breast Cancer, Washington University School of Medicine Study More...
•  Poor Sleep May Lead to Fibromyalgia in Women, Norwegian University of Science and Technology Study More...
•  Eating Fish Can Reduce the Risk of Diabetes, University of Valencia Study More...
•  Stem Cells May Help Heart Pump More Blood After Attack, University of Louisville Study More...
•  University of Barcelona Study Suggests New Benefits of Eating Nuts for Patients With Metabolic Syndrome More...
More General Clinical Research News
Events

Better Antibodies Through Better Antigen Design

Join SDIX at the Boston Cambridge Marriott on December 8th, 2011 for a symposium focused on next generation antibody development. At SDIX, a focus on the philosophy of better antigen design has resulted in dramatic improvements to the antibody production process. In a series of talks, our scientists and collaborators will discuss this antigen design philosophy and provide case studies to demonstrate the effectiveness of this methodology. In particular, these talks will focus on the use of SDIX's proprietary Genomic Antibody Technology™ and its ability to deliver antibodies that match end users' requirements.

Please click here for more information.
Latest Market Insight

The Emerging Role of Postmarketing Clinical Research

• Assess the industry impact of recent regulatory developments in postmarketing commitment trials and surveillance studies.
• Identify how postmarketing strategies can enhance product differentiation, market development, and formulary coverage.
• Use detailed case studies to understand the influence of phase IV trials upon lifecycle management, indication expansion, and reimbursement.

Click Here for More Information.
Tower: Facebook
Top Jobs
BioForest (Seattle, Washington)

Verinata Health, Inc.
Clinical Account Manager - Sales
Responsible for growing market share for the Verinata prenatal test. This individual will focus on the implementation of sales strategy, achievement of financial milestones and introduction of new clinical technology within the defined territory.

BioCapital (Bethesda, Maryland)

Technical Resources International
Clinical Information Specialist II
Primary responsibilities include the receipt and abstraction of protocol and/or contact information into the appropriate databases for use by the client and their collaborators in support of clinical trials.

BioMidwest (Chicago, Illinois)

Takeda Pharmaceuticals
Clinical Trial Manager / Sr. Clinical Trial Manager, Clinical Program Management
Responsible for the execution of Phase II - IV and other approved US and ex-US clinical studies, according to ICH-GCP and required regional regulations as applicable in support of the clinical strategies defined in the Takeda Integrated Development Plan Responsible for the execution of Phase II-IV and other (IDP).

Bio NC (Durham, North Carolina)

PAREXEL International
Medical Director Rheumatology Clinical Trials
Provide medical leadership and guidance/consulting to assist in the development of new drugs. Provide medical and scientific support to manage clinical trials, assess medical drug safety, and act as the physician lead on projects.

Biotech Beach (San Diego, California)

Sequenom Inc.
Clinical Laboratory Scientist
Responsible for the production of medical diagnostic testing in a CLIA lab. The scientist will ensure that complex molecular diagnostic assays and systems are performed under appropriate compliance and regulatory requirements.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


BioSpace Life Science Career Fairs are the biotech industry's premier career events. Featuring well-respected employers from around the nation, our job fairs attract top candidates in the biotech, pharmaceutical, life science and medical device industries.

With such a great number of recruiters and hiring managers from top biotech companies attending our career fairs, there are an abundance of opportunities available for job seekers. Many different disciplines within the industry are represented bringing a diversity of candidates to our job fairs.

Companies seeking pharmaceutical sales representatives and marketing jobs regularly attend our job fairs. Engineering and technical jobs can be found, as well as regulatory jobs and positions in QA/QC. Individuals desiring a science job or a research job will find many opportunities at our job fairs. In addition, hiring managers seeking candidates for clinical research jobs also attend our events.

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  VIRxSYS Corporation Issued U.S. Patents for its Lentiviral Vector and SMaRT RNA Platforms More...
•  Immunomedics, Inc. (IMMU) Awarded Additional U.S. Patent for Anti-CD20 Treatment of Autoimmune Diseases More...
•  Resverlogix Corporation (RVX.TO) Announces the Issuing of Patent Covering RVX-208 More...
More Patent News
HeadHtml
•  Nuvo Research Inc. (NRI.TO) Provides PENNSAID Commercial Update More...
More Drug Product News
Feature

Hot Company

Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285 U.S.A.
Phone: 317-276-2000

Lilly makes medicines that help people live longer, healthier, more active lives. We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. We have steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs.

More Company Profiles
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: